Appleseed

Appleseed Therapeutics is a clinical-stage biotechnology company focused on the identification and development of new treatments for rare diseases and oncology through drug repurposing. Founded by Dr. Michael S. Kinch, the company utilizes its proprietary platform, 'The Appleseed Project,' which leverages a comprehensive database of drug development history to identify existing compounds with untapped therapeutic potential. By focusing on established molecules, Appleseed aims to accelerate the development timeline and reduce the risks associated with traditional drug discovery. The company's mission is to translate academic and historical insights into viable clinical candidates for patients with high unmet medical needs.